Madhavan P N Nair1, Zainulabedin M Saiyed. 1. Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA. nairm@fiu.edu
Abstract
UNLABELLED: The United States is currently experiencing an entangled epidemic of HIV infection and use of different drugs of abuse, especially of methamphetamine (Meth). Blood monocyte-derived dendritic cells (DC) are the first line of defense against HIV-1 infection, and are the initial target of HIV-1 infection in injection drug users. DC-SIGN present on dendritic cells is the first molecule that facilitates HIV-1 infection independent of CD4 or HIV coreceptors. AIMS: The aim of this study was to evaluate whether Meth acts as a cofactor in the pathogenesis of HIV-1 infection. MAIN METHODS: Monocyte derived DCs, obtained from normal subjects were cultured with and without Meth±HIV-1B, followed by analyzing the gene and protein expression by real-time quantitative polymerase chain reaction (RT-PCR) and fluorescence-activated cell-sorting analyses, respectively. KEY FINDINGS: Our results show that Meth significantly enhances HIV infection, and downregulates the gene expression of chemokines and costimulatory molecules with reciprocal upregulation of HIV coreceptors and DC-SIGN by dendritic cells. SIGNIFICANCE: Better understanding of the role of Meth in HIV-1 disease susceptibility and the mechanism through which Meth mediates its effects on HIV-1 infection may help to devise novel therapeutic strategies against HIV-1 infection in Meth using HIV-1 infected population.
UNLABELLED: The United States is currently experiencing an entangled epidemic of HIV infection and use of different drugs of abuse, especially of methamphetamine (Meth). Blood monocyte-derived dendritic cells (DC) are the first line of defense against HIV-1 infection, and are the initial target of HIV-1 infection in injection drug users. DC-SIGN present on dendritic cells is the first molecule that facilitates HIV-1 infection independent of CD4 or HIV coreceptors. AIMS: The aim of this study was to evaluate whether Meth acts as a cofactor in the pathogenesis of HIV-1 infection. MAIN METHODS: Monocyte derived DCs, obtained from normal subjects were cultured with and without Meth±HIV-1B, followed by analyzing the gene and protein expression by real-time quantitative polymerase chain reaction (RT-PCR) and fluorescence-activated cell-sorting analyses, respectively. KEY FINDINGS: Our results show that Meth significantly enhances HIV infection, and downregulates the gene expression of chemokines and costimulatory molecules with reciprocal upregulation of HIV coreceptors and DC-SIGN by dendritic cells. SIGNIFICANCE: Better understanding of the role of Meth in HIV-1 disease susceptibility and the mechanism through which Meth mediates its effects on HIV-1 infection may help to devise novel therapeutic strategies against HIV-1 infection in Meth using HIV-1 infected population.
Authors: Supriya D Mahajan; Ravikumar Aalinkeel; Jessica L Reynolds; Bindukumar B Nair; Stanley F Fernandez; Stanley A Schwartz; Madhavan P N Nair Journal: Curr HIV Res Date: 2005-07 Impact factor: 1.581
Authors: E Langhoff; E F Terwilliger; H J Bos; K H Kalland; M C Poznansky; O M Bacon; W A Haseltine Journal: Proc Natl Acad Sci U S A Date: 1991-09-15 Impact factor: 11.205
Authors: Mariana M Mata; T Celeste Napier; Steven M Graves; Fareeha Mahmood; Shohreh Raeisi; Linda L Baum Journal: Eur J Pharmacol Date: 2015-02-10 Impact factor: 4.432
Authors: Brook L Henry; Mark A Geyer; Mahalah Buell; William Perry; Jared W Young; Arpi Minassian Journal: Behav Brain Res Date: 2012-08-31 Impact factor: 3.332
Authors: Susanna R Var; Tyler R C Day; Andrej Vitomirov; Davey M Smith; Virawudh Soontornniyomkij; David J Moore; Cristian L Achim; Sanjay R Mehta; Josué Pérez-Santiago Journal: AIDS Date: 2016-03-27 Impact factor: 4.177